Skip to main content

Table 2 ESR, and levels of CRP and PTX3 in TA patients

From: Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis

  Erythrocyte sedimentation rate, mm/h C-reactive protein, mg/l Pentraxin-3, ng/ml
Class of vascular involvement    
1 (n = 4) 28, 34 (4 to 44) 8.3, 6.0 (2.7 to 19) 5.5, 6.2 (2.9 to 6.7)
2A (n = 4) 15, 17 (7 to 22) 3.0, 1.0 (0.1 to 11) 15, 6.8 (6.2 to 44)
2B (n = 3) 33, 33 (29 to 38) 17, 12 (1.2 to 37) 5.3, 5.0 (3.9 to 7.0)
3 (n = 1) 4.0 2.0 6.3
4 (n = 0) NA NA NA
5 (n = 30) 21, 15 (1 to 78) 5.5, 1.9 (0.1 to 40) 8.2, 5.1 (3.0 to 5.1)
Presence of aneurysms (n = 16) 23, 15 (1 to 78) 5.7, 2.7 (0.3 to 40) 6.6, 5.8 (1.3 to 23)
Absence of aneurysms (n = 26) 20, 16 (2 to 68) 6.9, 1.2 (0.1 to 37) 11, 5.0 (2.2 to 55)
Active (NIH criteria n = 12) 34, 38 (3 to 73) 12, 8.6 (0.3 to 40) 12, 6.9 (2.2 to 55)
Inactive (NIH criteria n = 30) 16, 12 (1 to 78) 3.5, 1.9 (0.1 to 19) 7.1, 5.0 (1.3 to 44)
  1. Results are presented as mean, median (range). NA, not applicable; NIH, National Institutes of Health.